```html

Xylose Malabsorption: What You Need to Know

What is Xylose Malabsorption?

Xylose malabsorption (also called xylose intolerance) occurs when the small intestine is unable to absorb D‑xylose, a five‑carbon sugar found naturally in many fruits, vegetables, and grains. Because D‑xylose is a simple carbohydrate that does not require enzymatic breakdown, it is often used in medical testing to assess the absorptive capacity of the proximal small bowel. When absorption is impaired, patients may experience a range of gastrointestinal (GI) symptoms and, in severe cases, nutrient deficiencies.

In practice, xylose malabsorption is usually identified after a D‑xylose absorption test shows low levels of xylose in the urine or blood despite normal glucose results, indicating a problem with the mucosal surface rather than with pancreatic enzymes or bile salts.

Sources: Mayo Clinic; National Institutes of Health (NIH); Cleveland Clinic.

Common Causes

Most cases are secondary to damage or disease affecting the small‑bowel mucosa. The following conditions are the most frequently associated with xylose malabsorption:

• Coeliac disease – Autoimmune injury to the duodenal villi.
• Crohn’s disease – Inflammatory lesions anywhere in the small intestine.
• Short bowel syndrome – Resulting from surgical resection.
• Radiation enteritis – Mucosal injury after abdominal or pelvic radiation.
• Infectious enteritis – Chronic infections such as Giardia, Whipple’s disease, or tropical sprue.
• Whipple disease – Rare bacterial infection causing villous atrophy.
• Hirschsprung‑associated enterocolitis – In children with Hirschsprung disease.
• Chronic use of non‑steroidal anti‑inflammatory drugs (NSAIDs) – NSAID‑induced enteropathy.
• Ischemic bowel disease – Vascular compromise leading to mucosal damage.
• Congenital or acquired villous atrophy syndromes – e.g., autoimmune enteropathy.

Associated Symptoms

Because xylose is absorbed mainly in the proximal duodenum and jejunum, impaired uptake often presents with symptoms that overlap with other malabsorptive disorders:

• Abdominal bloating and distension
• Flatulence (excess gas)
• Steatorrhea – bulky, oily, foul‑smelling stools
• Diarrhea, especially after meals containing fruit or vegetable concentrates
• Weight loss or failure to thrive (in children)
• Fat‑soluble vitamin deficiencies (A, D, E, K) leading to night blindness, easy bruising, or bone pain
• Iron‑deficiency anemia due to concurrent malabsorption of iron
• Hypoglycemia‑like symptoms after a high‑xylose meal (cramping, shakiness)

These manifestations are not specific to xylose malabsorption alone, which is why targeted testing is essential.

When to See a Doctor

Persistent or worsening GI complaints that interfere with daily life should prompt a medical evaluation. Seek professional help promptly if you notice any of the following:

• Chronic diarrhea (>4 weeks) that does not improve with over‑the‑counter remedies.
• Unexplained weight loss (>5% of body weight) or growth failure in children.
• Signs of vitamin deficiency (e.g., night blindness, easy bruising, bone pain).
• Severe abdominal pain, especially after meals.
• Frequent, unexplained episodes of dehydration.
• History of gastrointestinal surgery, radiation, or a known inflammatory bowel disease.

Early diagnosis can prevent long‑term complications such as osteoporosis, anemia, and severe malnutrition.

Diagnosis

Diagnosing xylose malabsorption involves a combination of clinical suspicion, laboratory testing, and occasionally imaging or endoscopy.

1. D‑Xylose Absorption Test

• Patient ingests a measured dose of D‑xylose (usually 25 g) after an overnight fast.
• Blood samples are drawn at 2 hours and urine is collected over 5 hours.
• Low xylose levels in blood/urine with normal glucose indicate malabsorption.

2. Complementary Laboratory Studies

• Serum vitamin A, D, E, K levels.
• Iron studies (ferritin, transferrin saturation).
• Fecal fat quantification if steatorrhea is present.

3. Endoscopic Evaluation

• Upper endoscopy with duodenal biopsies to look for villous atrophy, inflammation, or infiltration.
• Capsule endoscopy or magnetic‑resonance enterography for disease beyond reach of standard endoscopy.

4. Imaging & Other Tests

• CT or MR enterography to assess for structural lesions, strictures, or ischemia.
• Serologic tests for celiac disease (tTG‑IgA, EMA) and inflammatory markers (CRP, ESR).

All test results must be interpreted in the context of the patient’s overall clinical picture.

Treatment Options

Therapy is directed at three goals: (1) correct the underlying disease, (2) restore nutrient absorption, and (3) relieve symptoms.

1. Treat the Underlying Cause

• Coeliac disease: Strict, lifelong gluten‑free diet.
• Inflammatory bowel disease (Crohn’s/ ulcerative colitis): Immunosuppressants, biologics (e.g., infliximab), or steroids as prescribed.
• Infections: Targeted antibiotics (e.g., metronidazole for Giardia).
• Radiation enteritis: Nutritional support and, in selected cases, hyperbaric oxygen therapy.
• NSAID‑induced injury: Discontinue offending drug; consider protective agents like misoprostol.

2. Nutritional Management

• Low‑xylose diet: Limit high‑xylose foods such as sweet corn, berries, and certain whole‑grain products. Most patients tolerate moderate amounts of cooked vegetables and low‑xylose fruits (e.g., bananas).
• Supplementation:
  • Fat‑soluble vitamins (A, D, E, K) – 1–2 times the Recommended Dietary Allowance (RDA) or as directed.
  • Iron & folic acid if anemia is present.
  • Calcium and vitamin D for bone health.
• Medium‑chain triglyceride (MCT) oil: Provides calories without requiring bile‑mediated absorption.

3. Symptom‑Focused Medications

• Antidiarrheals (e.g., loperamide) for occasional breakthrough diarrhea.
• Probiotics to improve gut flora balance – evidence suggests benefit in some malabsorptive conditions.
• Pancreatic enzyme replacements are usually not required for pure xylose malabsorption but may be added if pancreatic insufficiency coexists.

4. Monitoring and Follow‑up

• Repeat D‑xylose test 4–6 weeks after initiating therapy to gauge response.
• Periodic labs to monitor vitamin and mineral status.
• Bone density scan (DEXA) every 2–3 years for patients with chronic fat‑soluble vitamin deficiency.

Prevention Tips

Because most cases are secondary to another disease, “prevention” focuses on reducing risk factors for those conditions and protecting the gut lining:

• Adhere strictly to a gluten‑free diet if you have celiac disease.
• Maintain good hand hygiene and safe drinking water to avoid parasitic infections.
• Use NSAIDs sparingly; consider acetaminophen or COX‑2‑selective agents for chronic pain.
• Quit smoking and limit alcohol—both impair mucosal healing.
• Follow a balanced diet rich in fiber, but introduce high‑fiber foods gradually to avoid overwhelming a compromised intestine.
• Stay up‑to‑date with vaccinations (e.g., rotavirus, hepatitis A) that can prevent infectious enteritis.
• For patients requiring abdominal radiation, discuss protective strategies (e.g., shielding, dose fractionation) with the oncology team.

Emergency Warning Signs

---

References:

1. Mayo Clinic. “Malabsorption.” https://www.mayoclinic.org.
2. National Institutes of Health. “D‑Xylose Test.” https://medlineplus.gov.
3. Cleveland Clinic. “Celiac Disease.” https://my.clevelandclinic.org.
4. World Health Organization. “Guidelines on Food‑Based Dietary Recommendations.” 2022.
5. American College of Gastroenterology. “Management of Small Bowel Diseases.” Gastroenterology. 2021;161(5):1652‑1665.

```